Impaired visual evoked flow velocity response in cerebral amyloid angiopathy

Neurology

Volumn 71, Issue 18, 2008, Pages 1424-1430

  Smith, E E ^a,b   Vijayappa, M ^a   Lima, F ^a   Delgado, P ^a   Wendell, L ^a   Rosand, J ^a,b   Greenberg, S M ^a  

^a Hemorrhagic Stroke Research Program   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

AGED; ARTERY RESISTANCE; ARTICLE; BLEEDING; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EVOKED VISUAL RESPONSE; FEMALE; FLOW RATE; HUMAN; INHALATION; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VASCULAR AMYLOIDOSIS; VISUAL STIMULATION; WHITE MATTER; BLOOD FLOW VELOCITY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; LONGITUDINAL STUDY; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; POSTERIOR CEREBRAL ARTERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 58149237384     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000327887.64299.a4     Document Type: Article

References (40)

1. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke 1987;18:311-324.
2. Miao J, Xu F, Davis J, Otte-Holler I, Verbeek MM, Van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neu-roinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 2005;167:505-515.
3. Mueggler T, Sturchler-Pierrat C, Baumann D, Rausch M, Staufenbiel M, Rudin M. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J Neurosci 2002;22:7218-7224.
4. Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circulatory Physiol 2002;283: H315-323.
5. Niwa K, Younkin L, Ebeling C, et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci USA 2000;97:9735-9740.
6. Shin HK, Jones PB, Garcia-Alloza M, et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007;130:2310-2319.
7. Niwa K, Carlson GA, Iadecola C. Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 2000;20:1659-1668.
8. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52:702-708.
9. Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral hypo-perfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002;33:1986-1992.
10. Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 2004;63:1606-1612.
11. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983; 14:924-928.
12. Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 2005;58:459-462.
13. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007;62:229-234.
14. Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 2005; 110:222-231.
15. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipopro-tein E genotype and the risk of recurrent lobar intracere-bral hemorrhage. N Engl J Med 2000;342:240-245.
16. Chen Y-W, Gurol ME, Rosand J, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006;67:83-87.
17. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001;56:537-539.
18. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
19. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697-705.
20. Fried TR, Rosenberg RR, Lipsitz LA. Older community-dwelling adults' attitudes toward and practices of health promotion and advance planning activities. J Am Geriatr Soc 1995;43:645-649.
21. Kidwell CSR, el-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL. Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. J Neuroimaging 2001;11:229-235.
22. Kastrup A, Dichgans J, Niemeier M, Schabet M. Changes of cerebrovascular CO2 reactivity during normal aging. Stroke 1998;29:1311-1314.
23. Markus HS, Harrison MJ. Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus. Stroke 1992; 23:668-673.
24. Nandigam RN, Chen YW, Gurol ME, Rosand J, Greenberg SM, Smith EE. Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI. J Neuroimaging 2007;17:74-77.
25. Gurol ME, Irizarry MC, Smith EE, et al. Plasma betaamyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006;66:23-29.
26. Greenberg SM, O'Donnell HC, Schaefer PW, Kraft E. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999;53:1135-1138.
27. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology 1998;50:1699-1708.
28. Flibotte JJ, Hagan NR, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracere-bral hemorrhage. Neurology 2004;63:1059-1064.
29. Deppe M, Knecht S, Papke K, et al. Assessment of hemispheric language lateralization: a comparison between fMRI and fTCD. J Cereb Blood Flow Metab 2000;20: 263-268.
30. Sturzenegger M, Newell DW, Aaslid R. Visually evoked blood flow response assessed by simultaneous two-channel transcranial Doppler using flow velocity averaging. Stroke 1996;27:2256-2261.
31. Marti-Fabregas J, Belvis R, Guardia E, Cocho D, Marti-Vilalta JL. Relationship between transcranial Doppler and CT data in acute intracerebral hemorrhage. AJNR Am J Neuroradiol 2005;26:113-118.
32. Prvulovic D, Hubl D, Sack AT, et al. Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage 2002;17:1403-1414.
33. Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M. Activation-flow coupling differentiates between vascular and Alzheimer type of dementia. J Neurol Sci 2007;257:149-154.
34. Asil T, Uzuner N. Differentiation of vascular dementia and Alzheimer disease: a functional transcranial Doppler ultra-sonographic study. J Ultrasound Med 2005;24:1065-1070.
35. Bakker SL, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MM. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999;52:578-583.
36. van Dijk EJ, Prins ND, Hofman A, van Duijn CM, Koudstaal PJ, Breteler MM. Plasma beta amyloid and impaired CO(2)-induced cerebral vasomotor reactivity. Neurobiol Aging 2007;28:707-712.
37. Attwell D, Iadecola C. The neural basis of functional brain imaging signals. Trends Neurosci 2002;25:621-625.
38. 2 action of cat pial arterioles. Stroke 1977;8:226-229.
39. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-175.
40. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 2002;58: 1629-1634.